Results 151 to 160 of about 1,178,585 (315)

Impaired Atrial Natriuretic Peptide Secretion as a Marker of Advanced Atrial Fibrillation. [PDF]

Circ Rep
Oka S, Miyamoto K, Asahina C, Nakamura T, Wakamiya A, Ueda N, Nakajima K, Kamakura T, Wada M, Ishibashi K, Inoue Y, Aiba T, Kusano K.   +12 more
europepmc   +1 more source

Correction: Natriuretic peptide signaling as a therapeutic target in POTS: physiological opportunities and caveats. [PDF]

Clin Auton Res
Jordan J, Pesta D, Moro C.
europepmc   +1 more source

SPARCL1 and NT‐proBNP as biomarkers of right ventricular‐to‐pulmonary artery uncoupling in pulmonary hypertension

ESC Heart Failure, Volume 12, Issue 2, Page 1416-1426, April 2025.
Abstract Aims SPARCL1 was recently identified as a biomarker of right ventricular (RV) maladaptation in patients with pulmonary hypertension (PH), and N‐terminal pro‐brain natriuretic protein (NT‐proBNP) is an established biomarker of RV failure in PH. The present study investigated whether NT‐proBNP and SPARCL1 concentrations are associated with load ...
Oliver Dörr, Stanislav Keranov, Paulina van Wickern, Holger Nef, Christian Hamm, Pascal Bauer, Christian Troidl, Samuel Sossalla, Sandra Voss, Christoph Liebetrau, Manuel J. Richter, Henning Gall, Werner Seeger, Ardeschir Ghofrani, Athiththan Yogeswaran, Khodr Tello   +15 more
wiley   +1 more source

Natriuretic peptide signaling as a therapeutic target in POTS: physiological opportunities and caveats. [PDF]

Clin Auton Res
Jordan J, Pesta D, Moro C.
europepmc   +1 more source

Mortality risk stratification for Takotsubo syndrome: Evaluating CRP measurement alongside the InterTAK prognostic score

ESC Heart Failure, Volume 12, Issue 2, Page 1427-1436, April 2025.
Abstract Background and objectives Initially described as a benign acute cardiomyopathy, Takotsubo syndrome has been linked to elevated mortality rates. Emerging evidence suggests that unresolved myocardial inflammation may contribute to this adverse prognosis.
Loïc Faucher, Kensuke Matsushita, Shinnosuke Kikuchi, Taraneh Tatarcheh, Benjamin Marchandot, Amandine Granier, Said Amissi, Antonin Trimaille, Laurence Jesel, Patrick Ohlmann, Kiyoshi Hibi, Valérie Schini‐Kerth, Olivier Morel   +12 more
wiley   +1 more source

Recombinant human brain natriuretic peptide for the recovery stage of septic shock: an interventional study protocol. [PDF]

BMJ Open
Luo JC, Mou T, Li M, Feng WT, Yue RM, Pan C, Huang XB, Kattan E, Zhang Y, Pan LA.   +9 more
europepmc   +1 more source

The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro-B-type natriuretic peptide: a systematic review and individual patient data meta-analysis.

Journal of the American College of Cardiology, 2014
R. Rodseth, B. Biccard, Y. Manach, D. Sessler, G. Buse, L. Thabane, R. Schutt, D. Bolliger, L. Cagini, D. Cardinale, C. Chong, R. Chu, M. Cnotliwy, S. Somma, R. Fahrner, W. Lim, E. Mahla, R. Manikandan, F. Puma, W. Pyun, M. Radović, S. Rajagopalan, S. Suttie, T. Vanniyasingam, W. Gaal, Marek Waliszek, P. Devereaux   +26 more
semanticscholar   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

ESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad, Jeanne du Fay de Lavallaz, Michael J. Zhang, Thanat Chaikijurajai, Bo Ye, Prabhjot S. Nijjar, Julie A. Lahiri, Cindy M. Martin, Tamas Alexy, Markus Meyer   +9 more
wiley   +1 more source

Heart Failure With Preserved Ejection Fraction and Lower Natriuretic Peptide: Clinical Characteristics and Change in Natriuretic Peptide Levels. [PDF]

J Am Heart Assoc
Teramoto K, Nochioka K, Sakata Y, Nishimura K, Shimokawa H, Yasuda S, SUPPORT Trial Investigators *.   +6 more
europepmc   +1 more source

Localization and Mechanism of Secretion of B‐Type Natriuretic Peptide in Comparison With Those of A‐Type Natriuretic Peptide in Normal Subjects and Patients With Heart Failure

Circulation, 1994
H. Yasue, M. Yoshimura, H. Sumida, K. Kikuta, K. Kugiyama, M. Jougasaki, H. Ogawa, K. Okumura, M. Mukoyama, K. Nakao   +9 more
semanticscholar   +1 more source